Skip to main content
Medivisor India Treatment Logo
  • Home
              • Become a Partner

              +91 83407 80250

              Medivisor Logo

              Medivisor India Treatment is a trusted New Delhi–based medical travel partner connecting global patients to advanced, affordable, high-quality healthcare in India.

              • Medivisor House 359, Sector 1, Vaishali, Ghaziabad, (Delhi/NCR) India
              • +91 8340 780 250
              • info@medivisorhealth.com

              About Us

              • About Us
              • Our Services
              • Our Team
              • Our Medical Advisors
              • Our Safety Measures
              • Join Our Network
              • Contact Us

              India Treatment

              • Hospitals
              • Treatments
              • Treatment Cost
              • Treatment Process
              • Visa Process
              • Travel Guide
              • FAQs
              • Why Medivisor

              Gallery

              • Patient Testimonials
              • Patient Activities
              • News Coverage
              • Blog

              Get in Touch

              © 2026 Medivisor India Treatment. All rights reserved.

              Dr. Dr Dinesh Khullar

              Dr Dinesh Khullar

              Group Chairman - Nephrology & Renal Transplant Medicine

              33+ years experience

              D.M. (Nephrology) from PGIMER, Chandigarh M.D. ( Medicine), DMC & Hospital, Ludhiana ( Punjab University) MBBS from DMC & Hospital, Ludhiana ( Punjab University)
              1. Home
              2. Doctors
              3. Dr Dinesh Khullar

              About Dr Dinesh Khullar

              Dr. Khullar is a highly distinguished specialist in nephrology and renal transplant medicine with over 25 years of extensive clinical experience. He currently serves as the Chairman of the Department of Nephrology and Renal Transplant Medicine at Max Super Speciality Hospital, Saket, New Delhi, where he oversees clinical governance, academic programs, and advanced research initiatives.

              Mastery in Renal Transplantation

              He is recognized as one of India's leading renal transplant physicians, having been associated with over 5,000 successful kidney transplants. His expertise is particularly noted in managing highly complex cases, including ABO-incompatible transplants, procedures for highly sensitized recipients, and high-risk transplantations involving patients with significant comorbidities. Under his leadership, the transplant program at Max Hospital, Saket, has completed more than 1,200 successful procedures.

              Innovation in Dialysis and Renal Technology

              Dr. Khullar is credited with pioneering advanced dialysis techniques in Northern India, having established the region's first online hemodiafiltration (HDF) unit. This state-of-the-art facility provides enhanced clearance of toxins compared to conventional dialysis, representing a significant advancement in the management of end-stage renal disease and patient quality of life.

              Clinical Research and Academic Leadership

              A prominent figure in global clinical trials, Dr. Khullar has served as the national lead investigator for landmark studies such as DAPA-CKD and TRANSFORM. His contributions to medical literature are extensive, featuring numerous publications in high-impact national and international journals. He is also the editor of the specialized medical text, Lupus Nephritis: Pathogenesis & Current Management.

              Departmental Governance and Mentorship

              In his role as Chairman, Dr. Khullar is responsible for the academic development of DNB and clinical fellowship programs, ensuring rigorous training for the next generation of nephrologists. His leadership encompasses physician hiring, credentialing, and maintaining the highest standards of quality control and clinical excellence within the department.

              Dr. Dinesh Khullar at a Glance

              • Chairman of Nephrology and Renal Transplant Medicine at Max Super Speciality Hospital, Saket.

              • Over 25 years of experience with involvement in 5,000+ successful kidney transplants.

              • Specialist in ABO-incompatible and high-risk renal transplantations.

              • Pioneer of online hemodiafiltration (HDF) technology in North India.

              • National Lead Investigator for major clinical trials (DAPA-CKD, TRANSFORM).

              • Editor of authoritative texts on Lupus Nephritis and multiple peer-reviewed publications.

              D.M. (Nephrology) from PGIMER, Chandigarh
              M.D. ( Medicine), DMC & Hospital, Ludhiana ( Punjab University)
              MBBS from DMC & Hospital, Ludhiana ( Punjab University)
              Dr. Sushil Malik Memorial award oration ‘Pertinent use of drugs in chronic kidney disease’ at the annual convention of SDB IMA
              Lifetime Achievement Award by Human Care Charitable Trust 2011
              J.M. Patel Oration at Annual Conference of Indian Society of Organ Transplantation - 2015
              D.K. Pal Chaudhary memorial oration at Annual Meeting – 2005&nbsp
              of&nbsp
              Indian Medical Association, (SDB)
              Sushil Malik memorial oration at the Annual Convention of Indian Medical Association, (SDB)
              Lifetime Achievement Award by Human Care Charitable Trust - 2011

              Affiliated Hospitals

              Max Smart Super Specialty Hospital, Saket
              Max Smart Super Specialty Hospital, Saket

              Super Specialty

              New Delhi, Delhi NCR

              2013

              Estd.

              250+

              Beds

              300+

              Doctors

              Max Super Specialty Hospital, Saket
              Max Super Specialty Hospital, Saket

              Super Specialty

              New Delhi, Delhi NCR

              2006

              Estd.

              540+

              Beds

              450+

              Doctors

              May we help you?

              Enter digits only (6-15 digits). We'll add your country code.

              May we help you?

              Enter digits only (6-15 digits). We'll add your country code.

              Related Treatments

              Partial Nephrectomy (Kidney-Saving Surgery)
              Partial Nephrectomy (Kidney-Saving Surgery)

              Partial Nephrectomy Partial Nephrectomy, also known as "Kidney-Sparing Surgery," is a complex procedure where only the diseased part of the kidney (usually a tumor) is removed, leaving the healthy, functioning kidney tissue intact. This is the preferred treatment for smaller kidney tumors to preserve as much renal function as possible. When You Should Consider Partial Nephrectomy Small Renal Masses: Typically the first choice for tumors less than 4 cm (Stage T1a) and many tumors up to 7 cm (Stage T1b). Solitary Kidney: When a patient only has one functioning kidney, making it critical to avoid a total removal. Bilateral Kidney Tumors: When tumors are present in both kidneys, requiring a sparing approach on one or both sides. Pre-existing Kidney Disease: For patients with diabetes or hypertension who are at higher risk for future chronic kidney disease. Genetic Predisposition: For patients with conditions like Von Hippel-Lindau (VHL) syndrome who may develop multiple tumors over their lifetime. Methods of Partial Nephrectomy Robotic-Assisted (Da Vinci): The modern standard for precision. It allows the surgeon to perform complex suturing within the tight "ischemia" time window using 3D magnification. Laparoscopic Surgery: A minimally invasive approach using small incisions and specialized instruments to remove the tumor and repair the kidney. Open Surgery: Often reserved for very large or centrally located tumors where the surgeon needs direct physical access to the kidney. Nerve and Vessel Sparing: A technique focusing on identifying the specific arterial branches feeding the tumor to avoid clamping the entire renal blood supply. Renorrhaphy (Repair): The reconstructive phase where the "hole" left in the kidney is stitched closed using specialized sutures and hemostatic agents. How the Procedure Is Performed Anesthesia: Performed under General Anesthesia to ensure total patient comfort and muscle relaxation. The "Clamping" Phase: To prevent heavy bleeding, the surgeon temporarily clamps the Renal Artery. This must usually be completed in under 20–30 minutes to protect kidney health. Tumor Excision: The surgeon cuts out the tumor along with a small "margin" of healthy tissue to ensure no cancer cells remain. Hemostasis: Specialized "bolsters" or glues are often applied to the raw surface of the kidney to stop bleeding instantly. Unclamping: The artery clamp is removed, and the surgeon verifies that the kidney regains its pink color and shows no signs of active bleeding. Drain Placement: A small tube is left in the side for 24–48 hours to monitor for any internal fluid or blood collection. Pre-Procedure Preparation 3D Imaging: A high-resolution CT Scan or MRI with contrast is mandatory to map the "Renal Nephrometry Score" and tumor depth. Kidney Function Test: A DTPA Scan or serum creatinine test is performed to establish a baseline for how well both kidneys are working. Blood Prep: "Cross-matching" for blood units is done in advance due to the highly vascular nature of the kidney. Medication Audit: You must stop all blood thinners (Aspirin, Warfarin, etc.) 7–10 days prior to the operation. Fasting: Maintaining a "nil per oral" status for 8 hours before the procedure for anesthesia safety. Pre-Surgery Tests Complete Blood Count (CBC): To check baseline hemoglobin levels and ensure the body is ready for surgery. Coagulation Profile: Testing PT/INR and Platelet counts to ensure the kidney repair will clot effectively. Chest X-ray and EKG: Standard pre-operative checks to ensure heart and lung fitness for general anesthesia. Urinalysis: To rule out any existing urinary tract infections before the procedure. Electrolyte Panel: Checking sodium, potassium, and calcium levels to ensure the body’s chemistry is balanced. Life After Partial Nephrectomy (Recovery & Risks) Hospital Stay: Usually 2–3 days for Robotic/Laparoscopic surgery and 4–5 days for the Open approach. Catheterization: A Foley catheter is placed in the bladder for 1–2 days to monitor urine output and filtration. Activity Restrictions: No heavy lifting (over 5kg) or strenuous exercise for 6 weeks to prevent the repair from bleeding. Hydration Therapy: Drinking 2–2.5 litres of water daily is recommended to keep the kidneys working at a steady, healthy pace. Urine Leak Risk: If the repair isn't water-tight, a temporary JJ Stent may be placed to allow the kidney to heal. Follow-Up Imaging: A CT scan is typically repeated at 3 or 6 months to monitor the surgical site and ensure no recurrence. Why Specialized Treatment Is Highly Effective Preservation of Function: By saving the healthy part of the kidney, patients have a much lower risk of requiring dialysis in the future. Oncological Equivalent: Modern studies show that for appropriately selected tumors, a partial removal is just as effective as a total removal for cancer control. Robotic Precision: 2026 robotic technology allows for "ultra-selective clamping," where only the tumor's blood supply is stopped, leaving the rest of the kidney "warm." Faster Recovery: Minimally invasive techniques lead to less pain, smaller scars, and a quicker return to normal life compared to traditional surgery. Lower Cardiovascular Risk: Maintaining two functioning kidneys is linked to better long-term heart health and blood pressure control.